p53-regulated Transcriptional Program Associated with Genotoxic Stress-induced Apoptosis*

By using a genome-wide approach, we sought the identification of p53-regulated genes involved in cellular apoptosis. To this end, we assessed the transcriptional response of HCT116 colorectal cancer cells during apoptosis induced by the anticancer drug 5-fluorouracil as the function of p53 status, and we identified 230 potential targets that are regulated by p53. Previously identified p53 targets known to be involved in growth arrest and apoptosis were observed to be induced, thus validating the approach. Strikingly, we found that p53 regulates gene expression primarily through transcriptional repression (n = 189) rather than activation (n = 41), and selective blockade of p53-dependent gene repression resulted in the reduction in 5-fluorouracil-induced apoptosis. Reporter and chromatin immunoprecipitation assays demonstrated that p53 can suppress the promoter activities of three further studied candidate genes PLK, PTTG1, and CHEK1 but would only bind directly to PTTG1 and CHEK1 promoters, revealing that p53 can repress gene expression through both direct and indirect mechanisms. Moreover, RNAi-mediated knockdown of PLK and PTTG1 expression was sufficient to induce apoptosis, suggesting that repression of novel anti-apoptotic genes by p53 might contribute to a significant portion of the p53-dependent apoptosis. Our data support the divergent functions of p53 in regulating gene expression that play both synergistic and pleiotropic roles in p53-associated apoptosis.

[1]  P. Farnham,et al.  Characterizing transcription factor binding sites using formaldehyde crosslinking and immunoprecipitation. , 2002, Methods.

[2]  S. Elledge,et al.  The DNA damage response: putting checkpoints in perspective , 2000, Nature.

[3]  J. M. Lee,et al.  p53 regulates a G2 checkpoint through cyclin B1. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[4]  S. Melmed,et al.  Expression of pituitary-tumour transforming gene in colorectal tumours , 2000, The Lancet.

[5]  A. Fornace,et al.  Tumor Suppressor p53 Can Participate in Transcriptional Induction of the GADD45 Promoter in the Absence of Direct DNA Binding , 1998, Molecular and Cellular Biology.

[6]  P. C. Lee,et al.  DNA damage‐induced apoptosis requires the DNA‐dependent protein kinase, and is mediated by the latent population of p53 , 2004 .

[7]  Michael Q. Zhang,et al.  Use of Chromatin Immunoprecipitation To Clone Novel E2F Target Promoters , 2001, Molecular and Cellular Biology.

[8]  Yaolin Wang,et al.  Analyses of p53 Target Genes in the Human Genome by Bioinformatic and Microarray Approaches* 210 , 2001, The Journal of Biological Chemistry.

[9]  N. Hay,et al.  A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function , 2001, Oncogene.

[10]  C. Croce,et al.  Down-regulation of bcl-2 by p53 in breast cancer cells. , 1994, Cancer research.

[11]  D. Notterman,et al.  The transcriptional program following p53 activation. , 2000, Cold Spring Harbor symposia on quantitative biology.

[12]  K. Kinzler,et al.  PUMA mediates the apoptotic response to p53 in colorectal cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Levine,et al.  Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. , 1999, Genes & development.

[14]  Yuxin Yin,et al.  PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression , 2003, Nature.

[15]  M. Brattain,et al.  Expression of TGFα autocrine activity in human colon carcinoma CBS cells is autoregulated and independent of exogenous epidermal growth factor , 1998 .

[16]  K. Vousden,et al.  Mechanisms of p53-mediated apoptosis , 1999, Cellular and Molecular Life Sciences CMLS.

[17]  N. Lee,et al.  Identification of c-myc responsive genes using rat cDNA microarray. , 2000, Cancer research.

[18]  E. Appella,et al.  p53 transcriptional activity is essential for p53‐dependent apoptosis following DNA damage , 2000, The EMBO journal.

[19]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J P Luzio,et al.  Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. , 1998, Science.

[21]  James Brugarolas,et al.  Radiation-induced cell cycle arrest compromised by p21 deficiency , 1995, Nature.

[22]  R. Iggo,et al.  Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeast , 1998, Oncogene.

[23]  G. Getz,et al.  DNA microarrays identification of primary and secondary target genes regulated by p53 , 2001, Oncogene.

[24]  K. Vousden,et al.  PUMA, a novel proapoptotic gene, is induced by p53. , 2001, Molecular cell.

[25]  Yoichi Taya,et al.  Regulation of p53 by Hypoxia: Dissociation of Transcriptional Repression and Apoptosis from p53-Dependent Transactivation , 2001, Molecular and Cellular Biology.

[26]  C. Prives,et al.  p53: puzzle and paradigm. , 1996, Genes & development.

[27]  P. Ongusaha,et al.  p53‐mediated induction of Cox‐2 counteracts p53‐ or genotoxic stress‐induced apoptosis , 2002, The EMBO journal.

[28]  Sam W. Lee,et al.  p53 induction of heparin‐binding EGF‐like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades , 2001, The EMBO journal.

[29]  Xiaoqi Liu,et al.  Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Jürgen Bereiter-Hahn,et al.  Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells. , 2002, Journal of the National Cancer Institute.

[31]  N. Lee,et al.  Identification of Myc-mediated Death Response Pathways by Microarray Analysis* , 2002, The Journal of Biological Chemistry.

[32]  G. Zambetti,et al.  Inhibition of DNA topoisomerase II alpha gene expression by the p53 tumor suppressor , 1997, Molecular and cellular biology.

[33]  Xin Lu,et al.  Live or let die: the cell's response to p53 , 2002, Nature Reviews Cancer.

[34]  R. Iggo,et al.  Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Jiandong Chen,et al.  Transcriptional Repression of the Anti-apoptoticsurvivin Gene by Wild Type p53* , 2002, The Journal of Biological Chemistry.

[36]  Li Fang,et al.  p53 induction and activation of DDR1 kinase counteract p53‐mediated apoptosis and influence p53 regulation through a positive feedback loop , 2003, The EMBO journal.

[37]  A. Levine,et al.  Surfing the p53 network , 2000, Nature.

[38]  U. McDermott,et al.  Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling. , 2003, Cancer research.

[39]  Yunli Zhou,et al.  DNA Damage-induced Inhibition of Securin Expression Is Mediated by p53* , 2003, The Journal of Biological Chemistry.

[40]  Kevin Struhl,et al.  Targeted recruitment of Set1 histone methylase by elongating Pol II provides a localized mark and memory of recent transcriptional activity. , 2003, Molecular cell.

[41]  E. White,et al.  Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein , 1995, Molecular and cellular biology.

[42]  K. Kinzler,et al.  Disruption of p53 in human cancer cells alters the responses to therapeutic agents. , 1999, The Journal of clinical investigation.

[43]  Bhavya Sharma,et al.  Integrin α2 and Extracellular Signal-regulated Kinase Are Functionally Linked in Highly Malignant Autocrine Transforming Growth Factor-α-driven Colon Cancer Cells* , 2003, Journal of Biological Chemistry.

[44]  W. Deppert,et al.  Negative feedback regulation of wild‐type p53 biosynthesis. , 1995 .

[45]  Takao Takahashi,et al.  Polo‐like kinase 1 (PLK1) is overexpressed in primary colorectal cancers , 2003, Cancer science.

[46]  K. Kohn,et al.  UCN-01 inhibits p53 up-regulation and abrogates gamma-radiation-induced G(2)-M checkpoint independently of p53 by targeting both of the checkpoint kinases, Chk2 and Chk1. , 2002, Cancer research.

[47]  T. Volkert,et al.  E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints. , 2002, Genes & development.

[48]  M. Kinch,et al.  Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade , 2002, Oncogene.

[49]  N. Walworth Cell-cycle checkpoint kinases: checking in on the cell cycle. , 2000, Current opinion in cell biology.

[50]  G M Rubin,et al.  Functional analysis of CNK in RAS signaling. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Luquan Wang,et al.  Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression , 2003, Oncogene.

[52]  M. Bittner,et al.  Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses , 1999, Oncogene.

[53]  S. Knuutila,et al.  Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array , 2002, Oncogene.

[54]  M. White,et al.  Critical Contribution of Linker Proteins to Raf Kinase Activation* , 2002, The Journal of Biological Chemistry.

[55]  D. Green,et al.  A Matter of Life and Death , 2008, Science.